Safety and efficacy of 188-rhenium-labeled antibody to melanin in patients with metastatic melanoma.

Klein M, Lotem M, Peretz T, Zwas ST, Mizrachi S, Liberman Y, Chisin R, Schachter J, Ron IG, Iosilevsky G, Kennedy JA, Revskaya E, de Kater AW, Banaga E, Klutzaritz V, Friedmann N, Galun E, Denardo GL, Denardo SJ, Casadevall A, Dadachova E, Thornton GB

Open source

DOI: 10.1155/2013/828329
Published: 2013
Container: Journal of skin cancer
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1155/2013/828329,
  title = {Safety and efficacy of 188-rhenium-labeled antibody to melanin in patients with metastatic melanoma.},
  author = {Klein M and Lotem M and Peretz T and Zwas ST and Mizrachi S and Liberman Y and Chisin R and Schachter J and Ron IG and Iosilevsky G and Kennedy JA and Revskaya E and de Kater AW and Banaga E and Klutzaritz V and Friedmann N and Galun E and Denardo GL and Denardo SJ and Casadevall A and Dadachova E and Thornton GB},
  year = {2013},
  journal = {Journal of skin cancer},
  doi = {10.1155/2013/828329},
  url = {https://doi.org/10.1155/2013/828329}
}

RIS

TY  - JOUR
TI  - Safety and efficacy of 188-rhenium-labeled antibody to melanin in patients with metastatic melanoma.
AU  - Klein M
AU  - Lotem M
AU  - Peretz T
AU  - Zwas ST
AU  - Mizrachi S
AU  - Liberman Y
AU  - Chisin R
AU  - Schachter J
AU  - Ron IG
AU  - Iosilevsky G
AU  - Kennedy JA
AU  - Revskaya E
AU  - de Kater AW
AU  - Banaga E
AU  - Klutzaritz V
AU  - Friedmann N
AU  - Galun E
AU  - Denardo GL
AU  - Denardo SJ
AU  - Casadevall A
AU  - Dadachova E
AU  - Thornton GB
PY  - 2013
JO  - Journal of skin cancer
DO  - 10.1155/2013/828329
UR  - https://doi.org/10.1155/2013/828329
ER  -

APA

M, K., M, L., T, P., ST, Z., S, M., Y, L., R, C., J, S., IG, R., G, I., JA, K., E, R., AW, D. K., E, B., V, K., N, F., E, G., GL, D., SJ, D., A, C., E, D., & GB, T. (2013). Safety and efficacy of 188-rhenium-labeled antibody to melanin in patients with metastatic melanoma.. Journal of skin cancer. https://doi.org/10.1155/2013/828329

Source records

pubmed · retrieved 2026-09-25T10:20:13.731Z